Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 46% ± 24% | |
GABAergic neuron | 4 studies | 48% ± 18% | |
retina horizontal cell | 3 studies | 28% ± 4% | |
interneuron | 3 studies | 37% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 41% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 91% | 7942.57 | 2399 / 2642 | 77% | 16.20 | 546 / 705 |
adrenal gland | 12% | 211.23 | 32 / 258 | 66% | 37.33 | 152 / 230 |
pancreas | 13% | 137.99 | 41 / 328 | 58% | 5.98 | 103 / 178 |
liver | 0% | 0 | 0 / 226 | 5% | 0.68 | 19 / 406 |
ovary | 0% | 0 | 0 / 180 | 3% | 0.39 | 15 / 430 |
intestine | 0% | 1.57 | 2 / 966 | 2% | 0.29 | 12 / 527 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
stomach | 0% | 2.03 | 1 / 359 | 1% | 0.10 | 2 / 286 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.04 | 4 / 459 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.17 | 4 / 504 |
lung | 0% | 0 | 0 / 578 | 1% | 0.06 | 7 / 1155 |
esophagus | 0% | 0 | 0 / 1445 | 1% | 0.10 | 1 / 183 |
skin | 0% | 0.87 | 2 / 1809 | 0% | 0.07 | 2 / 472 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.05 | 3 / 901 |
breast | 0% | 0 | 0 / 459 | 0% | 0.02 | 1 / 1118 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097503 | Biological process | sialylation |
GO_0001574 | Biological process | ganglioside biosynthetic process |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0009100 | Biological process | glycoprotein metabolic process |
GO_0009311 | Biological process | oligosaccharide metabolic process |
GO_0006491 | Biological process | N-glycan processing |
GO_0006486 | Biological process | protein glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0003828 | Molecular function | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0033691 | Molecular function | sialic acid binding |
Gene name | ST8SIA3 |
Protein name | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (Ganglioside GD3 synthase ST8SIA3) (EC 2.4.3.8) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sia-a2,3-Gal-b1,4-Glc-NAc-R:a2,8-sialyltransferase) (hST8Sia III) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII) |
Synonyms | SIAT8C |
Description | FUNCTION: Catalyzes the transfer of sialic acid from a CMP-linked sialic acid donor onto a terminal alpha-2,3-, alpha-2,6-, or alpha-2,8-linked sialic acid of an acceptor, such as N-linked oligosaccharides of glycoproteins and glycolipids through alpha-2,8-linkages . Forms oligosialic and polysialic acid on various sialylated N-acetyllactosamine oligosaccharides of glycoproteins, including FETUB N-glycans, a2-HS-glycoprotein (AHSG) and alpha 2,3-sialylated glycosphingolipids, such as alpha 2,3-sialylparagloboside and ganglioside GM3 and to a lesser extent NCAM1 N-glycans . However, it is much more specific to N-linked oligosaccharides of glycoproteins than glycosphingolipids (By similarity). 2,3-sialylparagloboside serves as the best acceptor substrate among the glycolipids (By similarity). alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-6S-D-GlcNAc and monosialyl and disialyl N-acetyllactosamines are the best acceptor substrates among glycoproteins . May plays critical role in the striatum by mediating the formation of disialylated and trisialylated terminal glycotopes on N- and O-glycans of specific striatal proteins, regulating their distribution in lipid rafts, affecting their interaction with other binding partners, and subsequently modulating striatal functions (By similarity). . |
Accessions | O43173 ENST00000324000.4 K7EQB3 ENST00000586360.1 |